{"brief_title": "Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment", "brief_summary": "The purposes of the study is to determine whether blood sugar control is different between Lantus and a third oral anti-diabetic agent when added to patients who fail a thiazolidinedione and sulfonylurea or metformin combination.", "condition": "Diabetes Mellitus", "intervention_type": "Drug", "intervention_name": "Thiazolidinedione", "criteria": "Inclusion Criteria: - Patients between 18 - 79 years of age - With diagnosed type 2 diabetes for at least a year treated with stable doses of two oral antidiabetic drugs of which one is either Avandia or Actos for at least three months Exclusion Criteria: - Major cardiovascular events The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "79 Years", "healthy_volunteers": "No", "id": "NCT00046462.xml"}